IP Library Granted Patent US 9,855,309
Granted Patent B2
US 9,855,309 · App. 14/511,960 · Granted Jan 2, 2018

Compositions comprising extracts of boswellia, tea tree, aloe and lavender oil and methods of treating wounds, burns and skin injuries therewith

Inventors: Guy Chamberland (Boucherville, CA); Peter Bollen (Drongen, BE)
Assignees: Nutriquine N.V.; JAMP Pharma Corporation
A61K36/886A61K36/324A61K36/53A61K36/61A61L15/34A61L15/40A61L15/44A61L2300/30A61L2300/62
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,855,309
App. No.
14/511,960
Granted
Jan 2, 2018
Kind
B2
Abstract

Compositions for the treatment of sores, wounds, burns and other traumatized dermal tissues and skin injuries comprising Boswellia gum, gel, resin or extract, Tea Tree oil ( Melaleuca oil), an Aloe gel, resin, latex or extract and Lavender oil. The composition may be incorporated into a medical device such as a wound dressing or bandage, or formulated into a topical preparation such as an ointment, lotion or cream.

Claims (28)

1. A composition formulated as a topical ointment, cream or lotion for treating sores, wounds, burns or other traumatized dermal tissues and skin injuries, said composition comprising (i) an effective amount of Boswellia gum, gel, resin or extract, (ii) an effective amount of Tea Tree oil ( Melaleuca oil), (iii) an effective amount of an Aloe gel, resin, latex or extract, (iv) an effective amount of Lavender oil, and (v) a topically acceptable hydrophobic carrier.

2. The composition according to claim 1 , wherein the Boswellia gum, gel, resin or extract is obtained from leaves, plant or roots of Boswellia serrata, Boswellia sacra or Boswellia carterii.

3. The composition according to claim 1 , wherein the Boswellia gum, gel, resin or extract comprises about 10% to about 99% by weight boswellic acids.

4. The composition according to claim 1 , wherein the Boswellia gum, gel, resin or extract comprises about 50% to about 79% by weight boswellic acids.

5. The composition according to claim 1 , wherein the Tea Tree oil is obtained from leaves, root or plant of Melaleuca alternifolia.

6. The composition according to claim 1 , wherein the Tea Tree oil contains at least 10% by weight terpinene-4-ol.

7. The composition according to claim 1 , wherein the Aloe gel, resin, latex or extract is obtained from the leaves, root or plant of Aloe vera, Aloe africana, Aloe arborescens Miller, Aloe barbadensis, Aloe barbadesis, Aloe capensis or combinations thereof.

8. The composition according to claim 7 , wherein the Aloe extract is an aqueous or alcoholic extract.

9. The composition according to claim 1 , wherein the Lavender oil is obtained from the leaves, root, flower or plant of Lavandula officinalis , common lavender, English lavender, garden lavender, Lavandula angustifolia, Lavandula burnamii, Lavandula dentate, Lavandula dhofarensis, Lavandula latifolia, Lavandula officinalis, Lavandula stoechas or combinations thereof.

10. The composition according to claim 1 , further comprising one or more of the following components: a component or extract containing growth factors; an antibiotic; an analgesic; zinc oxide; vitamin A; vitamin E; an extract of Harpagophytum procumens (Devil's claw) root, Salix Alba (White Willow) plant or bark, Tanacetum Parthenium (Feverfew) herb or flower, Equisetum arvense (Horsetail), Spireae ulmaria (Dropwort), Betula alba (Birch), Urtica dioica (Stinging Nettle), Curcuma longa (Tumeric), marine algae or Gotu kola ( Centella asiatica Linn.); and total triterpenic fraction of Centella asiatica (TTECA).

11. The composition according to claim 10 , wherein the component or extract containing growth factors comprises colostrum, whey, blood, tissue, or any combination thereof.

12. The composition according to claim 1 , further comprising a component to absorb wound exudates, slowly release the active agents, or both.

13. The composition according to claim 12 , wherein the one or more components to absorb wound exudates, slowly release the active agents or both is selected from the group consisting of alginate, chitosan, hydrocolloid, chitin, polyoligosaccharide, liposome, a slow-releasing polymer or agent, and combinations thereof.

14. The composition of claim 13 , wherein the hydrocolloid comprises a natural, chemically modified, or synthetic hydrocolloid, or a combination thereof.

15. The composition of claim 13 , wherein the alginate comprises calcium alginate.

16. The composition of claim 1 , further comprising one or more component selected from the group consisting of Lanolin, Paraffin oil, Zinc oxide, cod liver oil, vegetable oil, and paraffinium liquid.

17. The composition of claim 1 , further comprising a preservative.

18. The composition of claim 17 , wherein the preservative is a hydroxybenzoate.

19. The composition of claim 1 , further comprising a scent agent to camouflage the odour of the composition.

20. The composition of claim 19 , wherein the scent agent comprises an essential oil of a plant, flower, or combination thereof.

21. The composition of claim 1 , wherein the Boswellia gum, gel, resin or extract, the Tea Tree oil ( Melaleuca oil), the Aloe gel, resin, latex or extract and the Lavender oil are combined in a ratio of about 2:2.8:1:0.4, respectively, of the Boswellia gum, gel, resin or extract, the Tea Tree oil ( Melaleuca oil), the Aloe gel, resin, latex or extract and the Lavender oil.

22. The composition of claim 21 , wherein the Aloe gel, resin, latex or extract is a 10% by weight gel.

23. The composition of claim 1 , wherein the topically acceptable hydrophobic carrier comprises petroleum jelly, paraffin and/or lanolin.

24. The composition of claim 1 , formulated as a topical ointment.

25. A wound dressing or bandage comprising an effective amount of the composition of claim 1 , wherein the composition is added to, coated on or embedded into the wound dressing or bandage.

26. The wound dressing or bandage of claim 25 , wherein the wound dressing is a fibrous wound dressing or a dressing for applying directly to wounds for occlusion or semi-occlusion.

27. A medical device comprising an effective amount of the composition as defined in claim 1 , wherein the composition is coated thereon or embedded within said medical device.

28. The medical device of claim 27 , wherein the medical device is a dressing, a bandage, or other semi-occlusive or occlusive material used in wound care.

Assignments (4)
SECURITY INTEREST Recorded Feb 11, 2016
From: JAMP PHARMA CORPORATION
To: BDC CAPITAL INC.
Reel/Frame 037764/0493 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2015
From: CURAPHYTE TECHNOLOGIES INC.
To: JAMP PHARMA CORPORATION
Reel/Frame 036424/0316 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2015
From: CHAMBERLAND, GUY
To: CURAPHYTE TECHNOLOGIES INC.
Reel/Frame 035739/0984 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2015
From: BOLLEN, PETER
To: NUTRIQUINE N.V.
Reel/Frame 035740/0025 →
Priority Claims (1)
CA 2684258 · Nov 3, 2009 · national
Continuity (2)
Continuation 13505978
Related Publication 20150030708A1 · Jan 29, 2015